China Pharma Holdings, Inc.
CPHI
$1.50
-$0.0634-4.06%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.84% | -52.50% | -40.97% | -4.07% | 22.50% |
| Total Depreciation and Amortization | -4.92% | 6.25% | 6.48% | 5.28% | 1.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,003.23% | 424.02% | 3,242.86% | 198.01% | 239.10% |
| Change in Net Operating Assets | 401.72% | 195.03% | 425.31% | 519.71% | -145.10% |
| Cash from Operations | 33.33% | -684.47% | 137.13% | 118.37% | -70.84% |
| Capital Expenditure | -233.91% | -215.27% | 82.42% | 80.41% | 97.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -200.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,437.39% | -215.27% | 39.26% | 80.41% | 97.14% |
| Total Debt Issued | -66.73% | 47.34% | 41.22% | -4.76% | 163.16% |
| Total Debt Repaid | 66.93% | 10.20% | -62.19% | 28.38% | 36.96% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.52% | 108.10% | -246.87% | 55.11% | 104.13% |
| Foreign Exchange rate Adjustments | -307.84% | 430.82% | 124.67% | 97.47% | 112.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.50% | 9.10% | 87.90% | 87.13% | 78.58% |